Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma

Ophthalmology. 1997 Nov;104(11):1785-92; discussion 1792-3. doi: 10.1016/s0161-6420(97)30025-6.

Abstract

Objective: The purpose of the study is to compare the prognostic significance of horizontal/marginal versus vertical/diffuse patterns of postirradiation local recurrence of posterior uveal melanoma.

Design: The study design was a nonrandomized, retrospective clinical study. Semiparametric and nonparametric statistical techniques were used.

Participants: Seven hundred sixty-six posterior uveal melanoma patients were studied.

Intervention: Either iodine-125 plaque or helium ion radiation therapy was performed.

Main outcome measures: Local tumor recurrence and systemic metastasis were measured.

Results: Local tumor recurrence was detected in 66 (8.6%) of 766 irradiated tumors. The 5-year actuarial rate of local recurrence was 10%. The recurrence pattem was horizontal/marginal in 27 patients (41%) and vertical/diffuse in 39 patients (59%). Systemic metastasis was detected in 5 patients (19%) with horizontal/marginal recurrence and in 19 patients (49%) with vertical/diffuse recurrence. After known metastatic risk factors were controlled, the relative risk for metastasis was 2.2 for horizontal/marginal recurrence and 5.1 for vertical/diffuse recurrence (P = 0.05). The actuarial rate of systemic metastasis was 2.9% per year for all patients, 6.3% per year for patients with horizontal/marginal recurrence, and 15.5% per year for patients with vertical/diffuse recurrence.

Conclusions: Postirradiation local recurrence of posterior uveal melanoma is a risk factor for systemic metastasis. Vertical/diffuse recurrences may be associated more strongly with metastatic disease than horizontal/marginal recurrences.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Brachytherapy*
  • Female
  • Helium / therapeutic use*
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Melanoma / radiotherapy
  • Melanoma / secondary*
  • Middle Aged
  • Neoplasm Recurrence, Local / etiology
  • Neoplasm Recurrence, Local / pathology*
  • Prognosis
  • Radioisotope Teletherapy*
  • Retrospective Studies
  • Risk Factors
  • Uveal Neoplasms / etiology
  • Uveal Neoplasms / pathology*
  • Uveal Neoplasms / radiotherapy

Substances

  • Iodine Radioisotopes
  • Helium